Jefferies analyst Brian Tanquilut raised the firm’s price target on RadNet (RDNT) to $100 from $82 and keeps a Buy rating on the shares. Ongoing strength in broader healthcare utilization, along with ...
Barclays raised the firm’s price target on RadNet (RDNT) to $85 from $79 and keeps an Overweight rating on the shares. The firm walked away from the RSNA Conference with a greater appreciation for the ...
RadNet's latest collaboration aims to create an AI control system for image interpretation to ensure AI scalability, performance monitoring and safety.